Clinical significance of a novel reticulocyte-based erythropoietin resistance index in hemodialysis patients: a retrospective study.
Eiko UedaTetsuya FujikawaYoshiyuki ToyaTadashi KujiMidori Kakimoto-ShinoYuki KawaiTomoyuki KawanoKengo AzushimaHiromichi WakuiKouichi TamuraPublished in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2021)
The ERIΔRetHb was significantly and independently associated with all-cause mortality in hemodialysis patients. This article is protected by copyright. All rights reserved.
Keyphrases